Introduction We investigated the potential impact of stage migration because of positron-
emission tomography (PET) scan staging on survival in the locally advanced (stage IIIA/B) …

7548 Background: Patients with stage III NSCLC are potentially curable using combined
modality therapy (CMT) with chemotherapy and radical radiation (RT). The use of PET-CT …

Purpose Our objective was to determine the impact of initial 18 F-FDG PET/CT (PET/CT)
staging on clinical stage and the management plan and the prognostic value of PET/CT in …

Introduction Surgery is the standard treatment for early stage non–small-cell lung cancer
(NSCLC). For medically inoperable patients, stereotactic ablative radiotherapy (SABR) has …

The Surveillance, Epidemiology and End Results database is designed to provide a
generalized cross-section of cancer care in the United States. It is increasingly being used to …

Background The benefit of invasive mediastinal nodal staging (IMNS) in addition to positron
emission tomography-computed tomography (PET/CT) is undefined for early stage non …

BACKGROUND Successful treatment of nonsmall cell lung carcinoma (NSCLC) with radical
radiotherapy (RT) requires accurate delineation of tumor extent. Conventional computed …

The optimal treatment of stage IIIA-N2 non–small cell lung cancer (NSCLC) continues to be
debated. This is partly due to the heterogeneity of the disease's presentation, the important …

We evaluate the correlation of clinical staging on positron emission tomography-computed
tomography (PET-CT) and pathologic staging and the prognostic value of PET-CT after …

Objectives: The extent of whether staging by fluorodeoxyglucose positron-emission
tomography (PET) impacts outcomes in American Veterans with stage I-III non–small-cell …